Drug Resistant Tuberculosis News and Research

RSS

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.

20 Nov 2023

Researchers develop new way to boost immune cells' ability to fight TB

Tuberculosis is old-;ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn't been cured yet.

27 Sep 2023

New UK funding will help tackle the world's most pressing health challenges

New UK funding will help achieve UN Sustainable Development Goals by boosting health security and improving health and wellbeing around the world.

21 Sep 2023

Beyond expectations: study finds treatment success gap in drug-resistant Tuberculosis

Researchers performed a review of global treatment outcomes of drug-resistant Tuberculosis.

27 Jun 2023

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.

1 Jun 2023

Fighting tuberculosis with the new MTB Strip Test Kit

Lecturers of the Faculty of Allied Health Sciences, Chulalongkorn University have developed MTB Strip Test Kit for Tuberculosis (TB) diagnosis that's accurate and easy to use, guaranteed by the 2023 Invention Award from the National Research Council of Thailand (NRCT) -; Another hope to reduce the spread of tuberculosis in Thailand.

28 Apr 2023

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

For over a century, El Paso has long been a sanctuary for individuals suffering from tuberculosis. It will soon be home to groundbreaking research that prevents the debilitating disease.

24 Mar 2023

How did people in Zimbabwe respond to drug-resistant tuberculosis alongside COVID-19?

In a recent study posted to the medRxiv* preprint server, researchers described the experiences and coping strategies of people who suffered from drug-resistant tuberculosis (DR-TB) in Zimbabwe between 2020 and 2021.

1 Mar 2023

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

In a recent study posted to the Preprints with The Lancet SSRN* server, a team of researchers in China developed a machine learning-based diagnostic tool to detect tuberculosis and drug-resistant tuberculosis using nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI MS) to determine metabolic fingerprints from serum samples.

28 Feb 2023

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

A new study discussed the findings of Chai et al., which revealed that triple specificity protein phosphatase (ptpB) secreted by Mycobacterium tuberculosis inhibits pyroptosis and the release of cytokines by macrophages, allowing M. tuberculosis to invade the immune system.

19 Dec 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Early success of shorter tuberculosis treatment in Nigeria could pave the way for nationwide rollout

Early success with Nigeria's implementation of the new and shorter six-month tuberculosis treatment regimen in four states could pave the way for its rollout nationwide, says an expert.

10 Jun 2022

New class of antibiotics found to be highly effective against drug-resistant tuberculosis

Infection by Mycobacterium tuberculosis kills 1.5 million people worldwide every year. Antibiotics to treat TB exist, but in recent years, multi-drug resistant (MDR), extensively drug-resistant (XDR) and totally drug-resistant (TDR) strains of the bacterium have developed.

31 May 2022

Drug Resistant Tuberculosis News and Research

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

Researchers develop new way to boost immune cells' ability to fight TB

New UK funding will help tackle the world's most pressing health challenges

Beyond expectations: study finds treatment success gap in drug-resistant Tuberculosis

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

Fighting tuberculosis with the new MTB Strip Test Kit

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

How did people in Zimbabwe respond to drug-resistant tuberculosis alongside COVID-19?

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

Exploring antibiotic resistance in the EU

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Early success of shorter tuberculosis treatment in Nigeria could pave the way for nationwide rollout

New class of antibiotics found to be highly effective against drug-resistant tuberculosis

New genetic markers could improve early detection of drug-resistant tuberculosis

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

Researchers identify the genetic changes responsible for drug resistance in tuberculosis

New web tool offers many capabilities vital to bacteria mutation research

High rates of TB in Latin American prisons constitute a “health and human rights crisis”, warns study

From surviving to thriving: a framework for long-term success in people with HIV

Kevin Broadbelt

Michael Stryker

Latest News